These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 12853979

  • 1. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.
    Pirkmaier A, Dow R, Ganiatsas S, Waring P, Warren K, Thompson A, Hendley J, Germain D.
    Oncogene; 2003 Jul 10; 22(28):4425-33. PubMed ID: 12853979
    [Abstract] [Full Text] [Related]

  • 2. Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development.
    Kong G, Chua SS, Yijun Y, Kittrell F, Moraes RC, Medina D, Said TK.
    Oncogene; 2002 Oct 17; 21(47):7214-25. PubMed ID: 12370811
    [Abstract] [Full Text] [Related]

  • 3. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.
    BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875
    [Abstract] [Full Text] [Related]

  • 4. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
    Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV.
    Nature; 1994 Jun 23; 369(6482):669-71. PubMed ID: 8208295
    [Abstract] [Full Text] [Related]

  • 5. Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis.
    Rojas P, Cadenas MB, Lin PC, Benavides F, Conti CJ, Rodriguez-Puebla ML.
    Oncogene; 2007 Mar 15; 26(12):1723-30. PubMed ID: 16983339
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ, Lee RJ, Troyer DA, Pestell RG, Windle JJ.
    Cancer Res; 2002 Apr 01; 62(7):2077-84. PubMed ID: 11929828
    [Abstract] [Full Text] [Related]

  • 7. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
    Bartkova J, Rajpert-de Meyts E, Skakkebaek NE, Bartek J.
    J Pathol; 1999 Apr 01; 187(5):573-81. PubMed ID: 10398124
    [Abstract] [Full Text] [Related]

  • 8. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
    Daphna-Iken D, Shankar DB, Lawshé A, Ornitz DM, Shackleford GM, MacArthur CA.
    Oncogene; 1998 Nov 26; 17(21):2711-7. PubMed ID: 9840935
    [Abstract] [Full Text] [Related]

  • 9. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
    Bartkova J, Lukas J, Müller H, Strauss M, Gusterson B, Bartek J.
    Cancer Res; 1995 Feb 15; 55(4):949-56. PubMed ID: 7850812
    [Abstract] [Full Text] [Related]

  • 10. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B.
    Cancer Res; 2007 Apr 01; 67(7):3135-44. PubMed ID: 17409420
    [Abstract] [Full Text] [Related]

  • 11. Mouse development and cell proliferation in the absence of D-cyclins.
    Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P.
    Cell; 2004 Aug 20; 118(4):477-91. PubMed ID: 15315760
    [Abstract] [Full Text] [Related]

  • 12. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
    Yu Q, Ciemerych MA, Sicinski P.
    Oncogene; 2005 Oct 27; 24(47):7114-9. PubMed ID: 16103884
    [Abstract] [Full Text] [Related]

  • 13. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.
    Bartkova J, Lukas J, Strauss M, Bartek J.
    Oncogene; 1998 Aug 27; 17(8):1027-37. PubMed ID: 9747882
    [Abstract] [Full Text] [Related]

  • 14. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
    Gadd M, Pisc C, Branda J, Ionescu-Tiba V, Nikolic Z, Yang C, Wang T, Shackleford GM, Cardiff RD, Schmidt EV.
    Cancer Res; 2001 Dec 15; 61(24):8811-9. PubMed ID: 11751403
    [Abstract] [Full Text] [Related]

  • 15. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
    Ma Y, Feng Q, Sekula D, Diehl JA, Freemantle SJ, Dmitrovsky E.
    Cancer Res; 2005 Jul 15; 65(14):6476-83. PubMed ID: 16024653
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
    Weroha SJ, Li SA, Tawfik O, Li JJ.
    Carcinogenesis; 2006 Mar 15; 27(3):491-8. PubMed ID: 16311245
    [Abstract] [Full Text] [Related]

  • 17. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53.
    Klein A, Guhl E, Tzeng YJ, Fuhrhop J, Levrero M, Graessmann M, Graessmann A.
    Oncogene; 2003 May 15; 22(19):2910-9. PubMed ID: 12771941
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology.
    Chooi KF, Carter DA, Biswas S, Lightman SL, Ho MY, Murphy D.
    Cancer Res; 1994 Dec 15; 54(24):6434-40. PubMed ID: 7987839
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
    Zinser GM, Welsh J.
    Carcinogenesis; 2004 Dec 15; 25(12):2361-72. PubMed ID: 15333467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.